Research Article
Comparison of Different Phenotypic Tests versus PCR in the Detection of Carbapenemase-Producing Pseudomonas aeruginosa Isolates in Hamadan, Iran
Table 4
Demographic characteristics of evaluated P. aeruginosa isolates and antibiogram resistance with three main antibiotics.
| Characteristics | No. examined | Imipenem resistance | Meropenem resistance | Doripenem resistance | No. (%) | -value | No. (%) | -value | No. (%) | -value |
| Age | | | | | | | | 0–10 | 9 | 5 (55.6) | 0.308 | 5 (55.6) | 0.441 | 5 (55.6) | 0.346 | 11–20 | 9 | 5 (55.6) | | 5 (55.6) | | 5 (55.6) | | 21–30 | 7 | 4 (57.1) | | 3 (42.8) | | 3 (42.8) | | 31–40 | 7 | 3 (42.8) | | 2 (28.6) | | 2 (28.6) | | 41–50 | 21 | 9 (42.8) | | 9 (42.8) | | 9 (42.8) | | 51–60 | 14 | 5 (35.7) | | 4 (28.6) | | 3 (21.4) | | 61–70 | 19 | 13 (68.4) | | 12 (63.1) | | 13 (68.4) | | 71–80 | 5 | 2 (40) | | 2 (40) | | 3 (60) | | 81–90 | 5 | 2 (40) | | 2 (40) | | 3 (60) | | 91–100 | 1 | 1 (100) | | 1 (100) | | 1 (100) | | Total no. | 97 | 49 (50.5) | | 45 (46.4) | | 47 (48.5) | |
| Gender | | | | | | | | Male | 70 | 34 (48.6) | 0.232 | 33 (47.1) | 0.488 | 34 (48.6) | 0.345 | Female | 27 | 15 (55.6) | | 12 (44.4) | | 13 (48.1) | | Total no. | 97 | 49 (50.5) | | 45 (46.4) | | 47 (48.5) | |
| Hospital ward | | | | | | | | Burn | 28 | 19 (67.8) | 0.223 | 19 (67.8) | 0.170 | 18 (64.3) | 0.154 | Surgery | 5 | 2 (40) | | 1 (20) | | 0 (0) | | Pulmonary | 11 | 5 (45.4) | | 4 (36.4) | | 3 (27.3) | | Neurology | 3 | 0 (0) | | 1 (33.3) | | 1 (33.3) | | Orthopedics | 1 | 0 (0) | | 0 (0) | | 1 (100) | | Trauma | 13 | 7 (53.8) | | 5 (38.4) | | 6 (46.1) | | NICU | 8 | 2 (25) | | 1 (12.5) | | 1 (12.5) | | ICU | 14 | 9 (64.3) | | 8 (57.1) | | 10 (71.4) | | Hematology | 2 | 1 (50) | | 0 (0) | | 1 (50) | | Infected | 12 | 4 (33.3) | | 6 (50) | | 6 (50) | | Total no. | 97 | 49 (50.5) | | 45 (46.4) | | 47 (48.5) | |
| Sample source | | | | | | | | BC | 22 | 14 (63.6) | | 12 (54.5) | | 12 (54.5) | | UC | 12 | 3 (25) | 0.082 | 4 (33.3) | 0.401 | 4 (33.3) | 0.243 | TC | 33 | 16 (48.5) | | 14 (42.4) | | 15 (45.4) | | TA | 5 | 3 (60) | | 3 (60) | | 4 (80) | | Wound | 15 | 9 (60) | | 7 (46.7) | | 8 (53.3) | | Sputum | 6 | 2 (33.3) | | 3 (50) | | 2 (33.3) | | CSF | 2 | 0 (0) | | 0 (0) | | 0 (0) | | Fluid | 1 | 1 (100) | | 1 (100) | | 1 (100) | | TT | 1 | 1 (100) | | 1 (100) | | 1 (100) | | Total no. | 97 | 49 (50.5) | | 45 (46.4) | | 47 (48.5) | |
| Hospitalization period | | | | | | | | 0-10 days | 56 | 20 (35.7) | | 18 (32.1) | | 14 (25) | | 11-29 days | 25 | 16 (64) | | 13 (52) | | 18 (72) | | 1-2 months | 16 | 13 (81.2) | 0.433 | 14 (87.5) | 0.455 | 15 (93.7) | 0.601 | Total no. | 97 | 49 (50.5) | | 45 (46.4) | | 47 (48.5) | |
|
|